CareyL.A., PerouC.M., LivasyC.A.Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.JAMA2006; 295: 2492–502.
2.
RosenbergL., BoggsD.A., WiseL.A.Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women.Cancer Epidemiol Biomarkers Prev2010; 19: 2073–9.
3.
AksoyS., DizdarO., HarputluogluH., AltundagK.Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience.Ann Oncol2007; 18: 1904–6.
4.
NarodS.A., DubéM.P., KlijnJ.Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.J Natl Cancer Inst2002; 94: 1773–9.
